When should residents of a skilled nursing facility be tested for influenza, and when is it appropriate to start empiric antiviral therapy without testing?

Testing and Empiric Treatment for Influenza in Skilled Nursing Facilities

In skilled nursing facilities, you should start empiric antiviral treatment immediately for any resident with suspected influenza without waiting for test results, given that SNF residents are universally high-risk (age ≥65 years and chronic medical conditions), and testing should be performed concurrently to guide outbreak management and cohorting decisions. 1

When to Treat Empirically (Without Waiting for Tests)

Start antiviral treatment immediately for:

• All residents ≥65 years with suspected influenza symptoms (fever, respiratory symptoms) during flu season 1
• Any resident with chronic medical conditions (which describes virtually all SNF residents) 1
• Any resident with severe or progressive illness regardless of test results 1
• Any resident requiring hospitalization for respiratory illness during flu season 1

The key principle: SNF residents meet multiple high-risk criteria by definition (advanced age, chronic conditions, congregate living), so empiric treatment should be the default approach. Treatment benefit persists even when started >48 hours after symptom onset in high-risk patients 2.

When and How to Test

You should test concurrently with starting treatment, but testing serves different purposes than treatment decisions:

Testing Indications:

• Confirm outbreak status in the facility (requires testing multiple symptomatic residents) 1
• Guide cohorting decisions to prevent spread 1
• Inform prophylaxis decisions for exposed residents 1
• Characterize viral strains during institutional outbreaks 1

Preferred Testing Method:

• Use RT-PCR or molecular assays (not rapid antigen tests) if available, as RIDTs have poor sensitivity and should only be used when molecular assays are unavailable 1
• If RIDT is used and negative, follow up with RT-PCR to confirm the negative result 1

Specific Clinical Algorithm for SNF Settings

During influenza season (typically November-March):

1. Resident develops fever and/or respiratory symptoms:

   • Start oseltamivir 75mg PO BID immediately (don't wait for tests) 1
   • Collect nasopharyngeal swab for RT-PCR testing 1
   • Isolate resident and implement droplet precautions

2. If 2+ residents develop influenza-like illness within 72 hours:

   • Declare potential outbreak
   • Test all symptomatic residents 1
   • Consider prophylaxis for exposed high-risk residents 1
   • Notify facility infection control and public health

3. Continue treatment for 5 days regardless of test results if clinical suspicion remains high 1

Common Pitfalls to Avoid

• Don't wait for test results to start treatment - this is the most critical error in SNF settings where residents are universally high-risk 1
• Don't rely on rapid antigen tests alone - they miss 20-50% of influenza cases; if used, confirm negative results with PCR 1
• Don't skip testing entirely - while treatment is empiric, testing is essential for outbreak management and infection control 1
• Don't assume vaccination prevents severe disease - vaccinated residents still need treatment when symptomatic 1
• Don't stop treatment if initial test is negative - if clinical suspicion is high, consider repeat testing with more sensitive assay 3

Treatment Duration Considerations

• Standard duration: 5 days for uncomplicated influenza 1
• Consider longer duration (>5 days) for immunocompromised residents or those with severe lower respiratory disease 1
• Monitor for bacterial superinfection if patient deteriorates after initial improvement or fails to improve after 3-5 days 1

The evidence strongly supports that in SNF settings, the question is not "test or treat" but rather "treat immediately AND test for outbreak management." The high-risk nature of the SNF population, combined with the mortality benefit of early antiviral therapy, makes empiric treatment the standard of care.